Preface content

  • Field test first to type foot-and-mouth disease outside of the lab

  • NC3Rs grant to reduce the number of chickens used in research

  • Pirbright scientists help define sheeppox costs to Mongolia

  • Pirbright’s National Vaccinology Centre finalist at Construction News Awards

  • Sequential vaccination identifies immune cells against multiple FMD serotypes

  • View current vacancies at Pirbright

Our research


Pirbright's progress...

Trim content

® The Pirbright Institute 2017 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.